Neoplasm of Breast Clinical Trials

11 recruitingLast updated: May 11, 2026

There are 11 actively recruiting neoplasm of breast clinical trials across 20 countries. Studies span Not Applicable, Phase 1, Phase 4. Top locations include Genova, Italy, Zurich, Switzerland, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.


Neoplasm of Breast Trials at a Glance

11 actively recruiting trials for neoplasm of breast are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Genova, Zurich, and Bethesda. Lead sponsors running neoplasm of breast studies include Brigham and Women's Hospital, Calibr, a division of Scripps Research, and BeOne Medicines.

Browse neoplasm of breast trials by phase

Treatments under study

About Neoplasm of Breast Clinical Trials

Looking for clinical trials for Neoplasm of Breast? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neoplasm of Breast trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neoplasm of Breast clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

Breast CancerBreast CarcinomaCancer of the Breast+1 more
National Cancer Institute (NCI)175 enrolled1 locationNCT07067138
Recruiting
Phase 1

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Metastatic Breast CancerHER2-negative Breast CancerAdvanced Solid Tumor+6 more
BeOne Medicines399 enrolled63 locationsNCT06120283
Recruiting

Swedish Ibrance Registries Insights (SIRI)

Malignant Neoplasm of Breast
Pfizer1,500 enrolled1 locationNCT04654208
Recruiting
Not Applicable

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Breast CancerTriple-Negative Breast CancerMetastatic Breast Cancer+3 more
Brigham and Women's Hospital214 enrolled1 locationNCT04030507
Recruiting
Phase 1

A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer

Breast Cancer MetastaticLocally Advanced Breast Cancer (LABC)Malignant Neoplasm of Breast
Calibr, a division of Scripps Research20 enrolled5 locationsNCT06878248
Recruiting
Not Applicable

Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

Malignant Neoplasm of Breast
Novian Health Inc.122 enrolled13 locationsNCT03463954
Recruiting
Phase 4

A Study of Revaree Plus in People With Breast Cancer

Breast CancerStage III Breast CancerHormone Receptor-Positive Breast Cancer+8 more
Memorial Sloan Kettering Cancer Center60 enrolled7 locationsNCT07042581
Recruiting
Not Applicable

Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer

Neoplasm of Breast
Centre Hospitalier Emile Roux300 enrolled9 locationsNCT04794075
Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

Breast CancerBreast Cancer MetastaticBreast Carcinoma+37 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano3,500 enrolled24 locationsNCT06805812
Recruiting
Not Applicable

A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection

Women's Health: Neoplasm of Breast
Umbria Bioengineering Technologies10,000 enrolled9 locationsNCT06291896
Recruiting
Not Applicable

Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery

Malignant Neoplasm of Breast
Instituto Brasileiro de Controle do Cancer36 enrolled1 locationNCT04669873